Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma

The current treatment for metastatic gastric cancer (MGC) consists of cisplatin and/or fluorouracil (5-FU) based combination chemotherapy, but cisplatin-based regimens are associated with considerable toxicity. We evaluated the efficacy and safety of a noncisplatin-, non-5-FU-containing regimen, doc...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, S R, Chun, J H, Yu, M S, Lee, J H, Ryu, K W, Choi, I J, Kim, C G, Lee, J S, Kim, Y W, Bae, J-M, Kim, H K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361264/
https://www.ncbi.nlm.nih.gov/pubmed/16641896
http://dx.doi.org/10.1038/sj.bjc.6603133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361264/
https://www.ncbi.nlm.nih.gov/pubmed/16641896
http://dx.doi.org/10.1038/sj.bjc.6603133

Ejemplares similares